Target intelligence / Profile preview

Single-stranded DNA binding protein 1, mitochondrial (SSBP1)

Target
SSBP1
Molecular classification
DNA-binding protein, Mitochondrial genome maintenance factor, Other
01

Overview

Single-stranded DNA binding protein 1, mitochondrial (SSBP1) is a highly conserved protein that binds to single-stranded DNA in the mitochondrial matrix, stabilizing unwound DNA and preventing secondary structure formation during replication and repair[2][3][5][7]. SSBP1 ensures proper replication and maintenance of the mitochondrial genome by interacting with key replisome components such as DNA polymerase γ and the mitochondrial helicase Twinkle, thereby promoting genome stability, mtDNA synthesis, and protecting the genome from damage[2][3][5]. SSBP1 is critical for mitochondrial biogenesis and adapts under proteotoxic stress by translocating to the nucleus and regulating gene expression[3]. Mutations in SSBP1 are linked to several severe mitochondrial disorders, including mtDNA depletion syndrome, Leigh syndrome, MELAS, and inherited optic neuropathies[2][3]. Overexpression or altered regulation of SSBP1 is associated with enhanced proliferation and poor prognosis in multiple malignancies, underscoring its role in both mitochondrial disease and cancer biology[5]. No drugs are currently known to directly target SSBP1, but its central role in mitochondrial genome maintenance makes it a potential therapeutic target and disease biomarker in relevant conditions[3][5].

Other names
Mitochondrial single-stranded DNA-binding proteinSSBPmtSSBMt-SSBOPA13SOSS-B1PWP1-interacting protein 17
02

Biological functions

Mitochondrial DNA replicationMitochondrial DNA repairPrevention of DNA secondary structuresGenome stabilityRegulation of mitochondrial biogenesisResponse to proteotoxic stressModulation of chaperone gene expressionDNA recombination
03

Disease associations

Mitochondrial disorders (esp. mtDNA depletion syndromes, Leigh syndrome, MELAS, optic atrophy)Cancer (glioblastoma, gastric cancer, osteosarcoma, colorectal cancer, hepatocellular carcinoma)Neurodegenerative disease
04

Safety considerations

Mutation or disruption causes mitochondrial depletion syndromes, optic neuropathies, compromised oxidative phosphorylation, increased cancer risk or drug resistance in tumors with SSBP1 overexpression
05

Biomarkers

mtDNA depletion or deletionSSBP1 expression level in certain cancersSSBP1 mutations for diagnosis of mitochondrial syndromes

Beyond the preview

Go deeper on Single-stranded DNA binding protein 1, mitochondrial (SSBP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Single-stranded DNA binding protein 1, mitochondrial (SSBP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call